Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Alternate/Reduced Risk 4,770 headlines found

2 Views

Vapor Products Market: E-vapor and Heat-not-Burn Devices - Global Outlook and Forecast 2018-2023 - ResearchAndMarkets.com

The growing global health awareness and technological developments aiding safer smoking is driving the global vapor products (e-vapor and heat-not-burn (HnB) devices) market and is expected to cross $43 billion by 2023, growing at an impressive CAGR of o
Business Wire
added Jan 26, 2018 11:46
4 Views

BANTAM Vape Premium E-liquid Launch Raises the Bar for Quality, Consistency & Capacity

Cutting through the noise and clutter of watered down imitators, BANTAM Vape is proud to announce the launch of its first five premium e-liquids, all in the Strawberry family, and all meticulously crafted to deliver the clean punch of flavor true vape ent
PR Newswire
added Jan 26, 2018 11:46
5 Views

PUBLIC HEALTH CONSEQUENCES OF E-CIGARETTES: CONCLUSIONS BY LEVEL OF EVIDENCE (PDF)

CONCLUSIVE EVIDENCE: Conclusion 3-1.There is conclusive evidence that e-cigarette use increases airborne concentrations of particulate matter and nicotine in indoor environments compared with background levels. Conclusion 4-1.There is conclusive evidence
National Academies Press
added Jan 26, 2018 00:45
6 Views

EDITORIAL: Just one cigarette a day seriously elevates cardiovascular risk

The take home message for smokers is that any exposure to cigarette smoke is too much. The message for regulators dealing with newly marketed “reduced risk” products is that any suggestion of seriously reduced CHD and stroke from using these products is
British Medical Journal
added Jan 26, 2018 00:31
7 Views

Script of Philip Morris International’s Presentation before the Tobacco Products Scientific Advisory Committee (TPSAC)

Mr. Chairman, we have an integrated 90-minute presentation with four different speakers. We’d appreciate the opportunity to deliver the full presentation. After that we’d be happy to answer any questions the committee may have.
PMI Science (philip Morris International)
added Jan 26, 2018 00:23
8 Views

PMI PRESENTS ON OUR MODIFIED RISK TOBACCO PRODUCT APPLICATION FOR IQOS BEFORE THE TOBACCO PRODUCTS SCIENTIFIC ADVISORY COMMITTEE (TPSAC)

On 24 January 2018, PMI presented on our Modified Risk Tobacco Product Application for IQOS before the Tobacco Products Scientific Advisory Committee (TPSAC). The presentation covers the IQOS system and heating technology, an outline of our scientific ass
PMI Science (philip Morris International)
added Jan 26, 2018 00:06
14 Views

GLTANTZ: FDA advisors say evidence doesn't back Philip Morris' claim that IQOS cuts disease risk

UCSF has submitted 10 public comments supporting the scientific conclusion that IQOS is not safer than conventional cigarettes and that even allowing "reduced exposure" claims would be misinterpreted as reduced harm claims. ...Other countries should not b
Center for Tobacco Control Research and Education (UCSF)
added Jan 26, 2018 00:03
6 Views

Big Tobacco Has a Lot Riding on FDA’s Stance Toward IQOS, the Latest Cigarette Alternative ($$)

The findings, which are to be released at the end of a two-day meeting, could help chart a new course for tobacco regulation in the U.S. and have enormous implications for U.S. public health. The stakes are also high for the Marlboro maker, which has inv
The Wall Street Journal Interactive Edition
added Jan 25, 2018 23:59
10 Views

FDA panel rejects Philip Morris's claims that new smokeless cigarette reduces harm

agreed with the company's claim that its smokeless cigarette reduces smokers’ exposure to harmful chemicals but said the company had not proved conclusively that that would result in less harm and disease. The new technology, called IQOS, consists of a t
Washington Post
added Jan 25, 2018 23:54
7 Views

IQOS Cigarette Alternative Fares Poorly Before FDA Panel ($$)

The panel of scientific experts voted overwhelmingly against Philip Morris’s proposed claim that switching completely to IQOS can reduce the risk of tobacco-related diseases. It also voted against the claim that IQOS presents less risk of harm than conti
The Wall Street Journal Interactive Edition
added Jan 25, 2018 23:53
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines